Literature DB >> 9669267

Risks of initiating therapy with sotalol for treatment of atrial fibrillation.

F I Marcus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9669267     DOI： 10.1016/s0735-1097(98)00186-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

Review 1.  Atrial fibrillation: choosing an antiarrhythmic drug.

Authors:  Todd Rudo; Peter Kowey
Journal:  Curr Cardiol Rep       Date:  2006-09       Impact factor: 2.931

2.  Should class III drugs be initiated in hospital to prevent drug-induced torsade de pointes arrhythmias?

Authors:  S C Verduyn; S K G Winckels; A P M Gorgels; P A Doevendans; M A Vos
Journal:  Neth Heart J       Date:  2003-02       Impact factor: 2.380

Review 3.  Cost effectiveness of therapies for atrial fibrillation. A review.

Authors:  M P Teng; L E Catherwood; D P Melby
Journal:  Pharmacoeconomics       Date:  2000-10       Impact factor: 4.981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.